Effect of Antioxidant Mineral Elements Supplementation in the Treatment of Hypertension in Albino Rats

Table 3

Effect of antioxidant minerals on total antioxidant, nitric oxide, and lipid peroxidation.

Group	Nitric oxide (μM)	TAS (mmol/L)	MDA; (nmol/mg tissue)
I	28.14±3.85	1.64±0.24	0.382±0.04
II	17.70±3.07^𝜌	0.70±0.17^𝜌	1.210±0.22^𝜌
III	31.55±6.16^𝛼	0.99±0.28^𝜌	0.549±0.11^𝛼
IV	22.00±5.62	1.13±0.26^𝛽,𝜌	0.569±0.08^𝛼
V-	18.81±3.01^𝛾	1.00±0.15^𝜌	0.545±0.11^𝛼
VI	30.81±5.67^𝛼	1.40±0.06^𝛼	0.512±0.14^𝛼

TAS: total antioxidant status, MDA: malondialdehyde, I: normotensive control, II: hypertensive control, III: group treated with copper, IV: group treated with manganese, V: group treated with zinc, and VI: group treated with all the minerals.
Values are expressed as Mean ± SD; 𝑛=5. ^𝛼𝑃<0.01 when compared with group II, ^𝛽𝑃<0.05 when compared with group II, ^𝜌𝑃<0.01 when compared with group I, and ^𝛾𝑃<0.05 when compare with group I by Dunnette’s multiple comparison test.